GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) P/E ratio
As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a P/E ratio of 16.0×. Over the past ten years it has ranged from 12.3× (April 2025) to 30.8× (March 2024); the current reading is higher than 29% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 18.0× | 0.54% |
| FY2024 | 17.9× | (28.55%) |
| FY2023 | 25.0× | 91.74% |
| FY2022 | 13.1× | 0.00% |
| FY2021 | 13.1× | 0.00% |
| FY2020 | 13.1× | 0.00% |
| FY2019 | 13.1× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 14.7× | (13.79%) |
| Mar 2026 | 17.0× | (5.33%) |
| Dec 2025 | 18.0× | 16.16% |
| Sep 2025 | 15.5× | 2.44% |
| 14 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. | 16.0× |
| BSX Boston Scientific Corporation compare | 17.9× |
| PHG Koninklijke Philips N.V. compare | 18.8× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 23.0× |
| STE STERIS plc compare | 27.1× |
| DXCM DexCom, Inc. compare | 33.2× |
| SNN Smith & Nephew SNATS, Inc. compare | 35.4× |
| EW Edwards Lifesciences Corporation compare | 49.8× |
| PEN Penumbra, Inc. compare | 78.4× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement